Africa Research Strategy & Market Entry Advisory

This is the work for biotechs and sponsors who are early in thinking about Africa — before there's a formal feasibility plan, sometimes before there's even a clear trial concept. We help you work through which countries or regions fit your disease area and patient population, which site and investigator networks are credible, what the regulatory and cultural landscape actually looks like, and how to shape an initial trial or protocol concept that's realistic for the market.

Best for: Biotechs and sponsors exploring Africa for the first time, or rethinking their approach after a false start.

Site Feasibility Assessment

Once there's a direction, we run a data-driven feasibility assessment: disease prevalence and patient population analysis, site capability and infrastructure review, regulatory and ethics-timeline mapping, and investigator/site-network evaluation. The goal is a clear, evidence-based go/no-go — not a checklist exercise.

Best for: Sponsors and CROs evaluating specific sites or regions, especially first-time entry into African markets.

Strategic Trial Oversight

Advisory-level oversight for trials already underway — periodic review of timeline, budget, and partner performance, with recommendations rather than hands-on day-to-day management.

Best for: Sponsors who want an experienced second set of eyes on a trial's strategic health, without adding operational execution support.

Not sure which service fits your trial stage? Get in touch, and we'll figure it out together.